Latest News

September 16, 2019
Oncologists may be able to use circulating tumor DNA (ctDNA) to guide treatment decisions and predict which patients will have disease recurrence, according to 2 studies in JAMA Oncology.
September 16, 2019
Amgen recently announced early phase 3 CANDOR study data, showing the triple-drug combination of carfilzomib (Kyprolis), along with dexamethasone and daratumumab (Darzalex, sold by Janssen), met its primary end point of progression-free survival (PFS), in patients with relapsed or refractory multiple myeloma (RRMM), with a 37% reduction in the risk of progression or death.  
 
September 16, 2019
The sleep timing preferences and patterns of adolescent girls are linked to an increased risk for obesity, with weaker, albeit non-significant, associations observed in boys, according to a new study.
September 16, 2019
The researchers found that HIV significantly increases the risk of atrial fibrillation—a leading cause of stroke—at the same rate as or higher than known risk factors, including diabetes and hypertension.
September 16, 2019
Oxycontin manufacturer Purdue Pharma files for bankruptcy; the rise in uninsured immigrants may be associated with fear of the Trump administration's crackdown on immigrants; an investigation has found that some cannabidiol (CBD) products are being spiked in Maryland.
September 15, 2019
Up to 12% of pharmacy spending may be on high-cost, low-value drugs that can be removed from formularies.
September 14, 2019
Using national electronic health record information on more than 40 million patients over a 20-year period, researchers have found that the proportion of Americans older than 18 years who have had a prior HIV test could be as low as 6.4%. However, they noted several limitations of their analysis.
September 14, 2019
Intensive lifestyle intervention focusing on weight loss may reduce cardiovascular events in selected type 2 diabetes patients yet have a detrimental treatment effect in some, according to recent research.
September 14, 2019
Home initiation of chronic noninvasive ventilation in patients with chronic obstructive pulmonary disease (COPD) with chronic hypercapnic respiratory failure was shown to be as safe as in-hospital initiation, and reduced costs by more than 50%, according to a new study.
September 14, 2019
A study investigating the functional connectivity of the praxis network in patients in the early stages of Parkinson’s disease (PD) found that dopaminergic therapy may normalize praxis abilities and related praxis networks during the early stages of the disease by facilitating the propagation of long-term representations of object-related actions to motor execution areas.
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.